Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 1/20 | 0.50 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | GLS | O94925 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
| ▸ | FNTB | P49356 | 2/20 | 0.45 |
| ▸ | SFRP1 | Q8N474 | 1/20 | 0.45 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.44 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.44 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13812235 | 0.90 | HPGD (0.60) | DDB1CRBNHPGDKDM4EPKM | |
| SCHEMBL9238271 | 0.88 | KDM4E (0.50) | DDB1CRBNHPGDKDM4EPKM | |
| SCHEMBL21182317 | 0.88 | DDB1 (0.42) | DDB1CRBNHPGDKDM4EPKM | |
| Ethane SCHEMBL897978 | 0.86 | HPGD (0.60) | HPGDKDM4ERECQLEPHX1USP2 | |
| SCHEMBL47319 | 0.86 | HPGD (0.60) | HPGDKDM4ERECQLEPHX1USP2 | |
| SCHEMBL9236069 | 0.86 | KDM4E (0.48) | DDB1CRBNHPGDKDM4EPKM | |
| SCHEMBL13812230 | 0.86 | DDB1 (0.48) | DDB1CRBNHPGDKDM4EPKM | |
| SCHEMBL4195097 | 0.86 | KDM4E (0.48) | DDB1CRBNHPGDKDM4EPKM | |
| SCHEMBL13812227 | 0.85 | DDB1 (0.47) | DDB1CRBNHPGDKDM4EPKM | |
| SCHEMBL1148424 | 0.84 | HPGD (0.58) | HPGDKDM4ERECQLEPHX1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111868031-B | Process for the preparation of N-alkoxycarbonylpiperidine derivatives and intermediates therefor | 有机合成药品工业株式会社 | 2023-10-03 | — | — | CN | disclosed |
| EP-3741745-B1 | METHOD FOR PRODUCING N-ALKOXYCARBONYLPIPERIDINE DERIVATIVE, AND INTERMEDIATE THEREFOR | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2023-04-26 | — | — | EP | disclosed |
| US-11332458-B2 | Method for preparing N-alkoxycarbonylpiperidine derivative, and intermediate therefor | YUKI GOSEI KOGYO CO., LTD. (JP) | 2022-05-17 | — | — | US | disclosed |
| US-20210122729-A1 | METHOD FOR PRODUCING N-ALKOXYCARBONYLPIPERIDINE DERIVATIVE, AND INTERMEDIATE THEREFOR | YUKI GOSEI KOGYO CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
| EP-3741745-A1 | METHOD FOR PRODUCING N-ALKOXYCARBONYLPIPERIDINE DERIVATIVE, AND INTERMEDIATE THEREFOR | Yuki Gosei Kogyo Co., Ltd. (JP) | 2020-11-25 | — | — | EP | disclosed |
| CN-111868031-A | Process for producing N-alkoxycarbonylpiperidine derivative and intermediate therefor | 有机合成药品工业株式会社 | 2020-10-30 | — | — | CN | disclosed |
| WO-2019142900-A1 | METHOD FOR PRODUCING N-ALKOXYCARBONYLPIPERIDINE DERIVATIVE, AND INTERMEDIATE THEREFOR | 有機合成薬品工業株式会社 | 2019-07-25 | — | — | WO | disclosed |
| EP-1400511-B1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI YAKUHIN KOGYO KK (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-6900326-B2 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2005-05-31 | — | — | US | disclosed |
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1400511-A1 | Methods of producing n-alkoxycarbonylpiperidine derivatives and intermediates therefor | YUKI GOSEI KOGYO CO., LTD. (JP) | 2004-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11332458-B2 | Method for preparing N-alkoxycarbonylpiperidine derivative, and intermediate therefor | ALDH7A1, FAR1, ADH1C | DDB1 4779/4885CRBN 3901/4885HPGD 276/4885 |
| US-20210122729-A1 | METHOD FOR PRODUCING N-ALKOXYCARBONYLPIPERIDINE DERIVATIVE, AND INTERMEDIATE THEREFOR | ALDH7A1, FAR1, ACSL1 | DDB1 4802/4885CRBN 4048/4885HPGD 205/4885 |
| US-20040063953-A1 | Method of producing N-alkoxycarbonylpiperidine derivative, new compound as raw material therefor, and method of producing the compound | ORMDL3, MRPS18A, ACSL3 | DDB1 4310/4885CRBN 2854/4885HPGD 2553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.